These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 576356)

  • 1. On the absorption of proscillaridin A after single oral doses to normal and achlorhydric subjects.
    Andersson KE; Bergdah B; Bertler A; Redfors A
    Acta Pharmacol Toxicol (Copenh); 1977 Jan; 40(1):153-60. PubMed ID: 576356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of proscillaridin A in thoracic duct lymph after single oral doses in man.
    Andersson KE; Bergdahl B; Dencker H; Wettrell G
    Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):280-4. PubMed ID: 576557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary excretion and enterochepatic recycling of proscillaridin A after oral adminstration to man.
    Andersson KE; Bergdahl B; Wettrell G
    Eur J Clin Pharmacol; 1977 Apr; 11(4):273-6. PubMed ID: 862647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proscillaridin activity in portal and peripheral venous blood after oral administration to man.
    Andersson KE; Bergdahl B; Dencker H; Wettrell G
    Eur J Clin Pharmacol; 1977 Apr; 11(4):277-81. PubMed ID: 862648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the pharmacokinetics of proscillaridin A in man.
    Andersson KE; Bertler A; Redfors A
    Eur J Clin Pharmacol; 1975 Aug; 8(6):421-5. PubMed ID: 1233243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition rate of proscillaridin A in man after multiple oral doses.
    Bergdahl B
    Arzneimittelforschung; 1979; 29(2):343-5. PubMed ID: 582147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro stability of proscillaridin A.
    Andersson KE; Bertler A; Redfors A
    Eur J Clin Pharmacol; 1975 Feb; 8(2):135-9. PubMed ID: 9294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations during repeated intravenous and oral methyl-proscillaridin application in man.
    Belz GG; Nübling H; Belz G
    Arzneimittelforschung; 1976 Feb; 26(2):277-8. PubMed ID: 947212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability in vitro of methylproscillaridin.
    Bergdahl B; Andersson KE
    Eur J Clin Pharmacol; 1977 Apr; 11(4):267-71. PubMed ID: 16755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enteral availability and therapeutic activity of proscillaridin-4'-methyl ether (author's transl)].
    Krämer KD; Hochrein H
    Arzneimittelforschung; 1976 Apr; 26(4):579-83. PubMed ID: 989015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of methyl proscillaridin in healthy man.
    Belz GG; Schreiter H; Wolf GK
    Eur J Clin Pharmacol; 1976 Jun; 10(2):101-8. PubMed ID: 786669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of mathematical methods and computer technics for monitoring the concentration of digitalis glycosides in the body of patients with symptoms of overdigitalization].
    Tytman B
    Pol Tyg Lek; 1981 Mar; 36(10):373-7. PubMed ID: 7279733
    [No Abstract]   [Full Text] [Related]  

  • 13. Excretion of methylproscillaridin in patients with a biliary fistula.
    Staud R; Rietbrock N; Fassbender HP
    Eur J Clin Pharmacol; 1975 Dec; 9(2-3):99-103. PubMed ID: 1233271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Construction of tables facilitating daily control of treatment with proscillaridin A].
    Tytman B
    Pol Tyg Lek; 1979 Dec; 34(49):1917-21. PubMed ID: 575563
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of proscillaridin in plasma by radioimmunoassay.
    Kojima K; Yamamoto K; Terauchi Y; Kagemoto A; Naruto S; Nakanishi Y
    J Pharmacobiodyn; 1986 Aug; 9(8):665-71. PubMed ID: 3783410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [14,15-beta-oxido analog of proscillaridin (HOE 040). A new cardiac glycoside with low arrhythmic activity and greater absorption ratio].
    Lindner E; von Reitzenstein G; Schöne HH
    Arzneimittelforschung; 1979; 29(2):221-6. PubMed ID: 109100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Investigations on the Stability of Proscillaridine, Proscillaridine-3'-methylether and Proscillaridine-4'-methylether in Artificial Gastric and Intestinal Fluids (author's transl)].
    Einig H
    Arzneimittelforschung; 1976; 26(7):1276-9. PubMed ID: 12764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enteral availability and suggested dosages for methyl proscillaridin in decompensated heart patients].
    Krämer KD; Hochrein H
    Verh Dtsch Ges Inn Med; 1975; 81():1669-71. PubMed ID: 1227053
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect and plasma level of methylproscillaridin and beta-acetyldigitoxin following long term administration in man].
    Belz GG; Nübling H; Strauch M
    Verh Dtsch Ges Kreislaufforsch; 1975; 41():315-9. PubMed ID: 821263
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of food intake on the bioavailability of sulpiride from AEA film-coated tablet having a pH-dependent dissolution characteristic in normal or drug-induced achlorhydric subjects.
    Shinkuma D; Hamaguchi T; Kobayashi M; Yamanaka Y; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1991 Aug; 29(8):303-9. PubMed ID: 1743804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.